Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.14 | N/A |
| PEG Ratio (TTM) | -2.31 | N/A |
| P/S Ratio (TTM) | 0.94 | N/A |
| P/B Ratio (TTM) | 2.14 | N/A |
| P/FCF Ratio (TTM) | 7.17 | N/A |
| Price to 5YR AVG Earnings Ratio | 2.54 | N/A |
| Price to 5YR AVG FCF Ratio | 12.52 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.10% | N/A |
| ROE (TTM) | 14.84% | N/A |
| Net Profit Margin (TTM) | 6.31% | N/A |
| ROIC 5YR AVG | 13.44% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5.30% | 35.66% | 38.44% |
| Revenue | 1.78% | 9.11% | 7.32% |
| Net Income | -5.93% | 35.61% | 36.84% |
| Cash Flow | 163.89% | 22.81% | 27.09% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.74 | N/A |
| Quick Ratio (TTM) | 2.74 | N/A |
| D/E Ratio (TTM) | 0.40 | N/A |
| Interest Coverage (TTM) | 7.28 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.06 | N/A |
| LTL to 5YR AVG FCF | 2.33 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.95% | N/A |